2.05
-0.04 (-1.91%)
| Penutupan Terdahulu | 2.09 |
| Buka | 2.04 |
| Jumlah Dagangan | 421,863 |
| Purata Dagangan (3B) | 786,473 |
| Modal Pasaran | 70,423,648 |
| Harga / Jualan (P/S) | 0.120 |
| Harga / Buku (P/B) | 0.460 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2025 - 11 Aug 2025 |
| Margin Keuntungan | -18.21% |
| Margin Operasi (TTM) | -7.62% |
| EPS Cair (TTM) | -3.12 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 4.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 286.38% |
| Nisbah Semasa (MRQ) | 1.50 |
| Aliran Tunai Operasi (OCF TTM) | -34.49 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -11.40 M |
| Pulangan Atas Aset (ROA TTM) | -2.31% |
| Pulangan Atas Ekuiti (ROE TTM) | -47.95% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Bercampur |
| Diagnostics & Research (Global) | Bercampur | Bercampur | |
| Stok | Inotiv, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -4.0 |
| Purata | -1.30 |
|
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 11.32% |
| % Dimiliki oleh Institusi | 23.80% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Vantage Point Financial Llc | 31 Mar 2025 | 336,546 |
| Kpp Advisory Services Llc | 31 Mar 2025 | 249,897 |
| Fourworld Capital Management Llc | 31 Mar 2025 | 196,449 |
| Tradewinds, Llc. | 31 Mar 2025 | 175,383 |
| Massar Capital Management, Lp | 31 Mar 2025 | 150,000 |
| Julat 52 Minggu | ||
| Median | 5.00 (143.90%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Lake Street | 08 May 2025 | 5.00 (143.90%) | Beli | 2.22 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| NEFF R MATTHEW | - | 1.88 | -2,000 | -3,760 |
| Jumlah Keseluruhan Kuantiti Bersih | -2,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -3,760 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 1.88 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| NEFF R MATTHEW | Pengarah | 01 Jul 2025 | Jual automatik (-) | 2,000 | 1.88 | 3,760 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 22 May 2025 | Pengumuman | Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025 |
| 07 May 2025 | Pengumuman | Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update |
| 23 Apr 2025 | Pengumuman | Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |